R

Repligen Corp

RGEN

165.630
USD
-1.97
(-1.18%)
Market Open
Volume
26,022
EPS
0
Div Yield
0
P/E
-4,787
Market Cap
8,053,734,412
Related Instruments
B
BEAM
-1.310
(-4.14%)
30.330 USD
C
CDNA
3.680
(18.46%)
23.610 USD
C
CRSP
-2.450
(-4.28%)
54.840 USD
E
EDIT
-0.28500
(-5.26%)
5.13500 USD
G
GH
-1.770
(-5.04%)
33.380 USD
N
NTLA
-1.100
(-4.19%)
25.130 USD
N
NVTA
0
(0%)
0.000000 USD
P
PSTG
-3.110
(-5.19%)
56.830 USD
REGN
13.14
(1.22%)
1,091.19 USD
V
VCYT
-1.040
(-4.34%)
22.940 USD
VRTX
9.75
(1.97%)
505.40 USD
News

Title: Repligen Corp

Sector: Healthcare
Industry: Medical Instruments & Supplies
Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.